In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.

Q: SECTION 1. SHORT TITLE.

This Act may be cited as the ''Genetically Engineered Food Right-
to-Know Act''.

SEC. 2. PURPOSE AND FINDINGS.

(a) Purpose.--The purpose of this Act is to establish a consistent
and enforceable standard for labeling of foods produced using genetic
engineering, including fish, thereby providing consumers with knowledge
of how their food is produced.
(b) Findings.--Congress finds that--
(1) the process of genetically engineering food organisms
results in material changes to food derived from those
organisms;
(2) the Food and Drug Administration requires the labeling
of more than 3,000 ingredients, additives, and processes;
(3) individuals in the United States have a right to know
if their food was produced with genetic engineering for a
variety of reasons, including health, economic, environmental,
religious, and ethical;
(4) more than 60 countries, including the United Kingdom
and all other countries of the European Union, South Korea,
Japan, Brazil, Australia, India, China, and other key United
States trading partners have laws or regulations mandating
disclosure of genetically engineered food on food labels;
(5) in 2011, Codex Alimentarius, the food standards
organization of the United Nations, adopted a text that
indicates that governments can decide on whether and how to
label foods produced with genetic engineering; and
(6) mandatory identification of food produced with genetic
engineering can be a critical method of preserving the economic
value of exports or domestically sensitive markets with
labeling requirements for genetically engineered foods.

SEC. 3. AMENDMENTS TO THE FEDERAL FOOD, DRUG, AND COSMETIC ACT.

(a) In General.--Section 403 of the Federal Food, Drug, and
Cosmetic Act (21 U.S.C. 343) is amended by adding at the end the
following:
''(z)(1) If it is a food that has been genetically engineered or
contains 1 or more genetically engineered ingredients, unless such
information is clearly disclosed, as determined by the Secretary.
''(2) This paragraph does not apply to food that--
''(A) is served in restaurants or other similar eating
establishments, such as cafeterias and carryouts;
''(B) is a medical food (as defined in section 5(b) of the
Orphan Drug Act);
''(C) is a food that would be subject to this paragraph
solely because it was produced using a genetically engineered
vaccine; or
''(D) is a food or processed food that would be subject to
this paragraph solely because it includes the use of a
genetically engineered processing aid (including yeast) or
enzyme.
''(3) In this paragraph:
''(A) The term 'genetic engineering' means a process
involving the application of--
''(i) in vitro nucleic acid techniques, including
recombinant deoxyribonucleic acid (DNA) and direct
injection of nucleic acid into cells or organelles; or
''(ii) fusion of cells beyond the taxonomic family
that--
''(I) overcome natural physiological
reproductive or recombinant barriers; and
''(II) are not techniques used in
traditional breeding and selection.
''(B) The term 'genetically engineered', used with respect
to a food, means a material intended for human consumption that
is--
''(i) an organism that is produced through the
intentional use of genetic engineering; or
''(ii) the progeny of intended sexual or asexual
reproduction (or both) of 1 or more organisms that is
the product of genetic engineering.
''(C) The term 'genetically engineered ingredient' means a
material that is an ingredient in a food that is derived from
any part of an organism that has been genetically engineered,
without regard to whether--
''(i) the altered molecular or cellular
characteristics of the organism are detectable in the
material; and
''(ii) the organism is capable for use as human
food.''.
(b) Guaranty.--
(1) In general.--Section 303(d) of the Federal Food, Drug,
and Cosmetic Act (21 U.S.C. 333(d)) is amended--
(A) by striking ''(d)'' and inserting ''(d)(1)'';
and
(B) by adding at the end the following:
''(2)(A) No person shall be subject to the penalties of
subsection (a)(1) for a violation of subsection (a), (b), or
(c) of section 301 involving food that is misbranded within the
meaning of section 403(z) if such person (referred to in this
paragraph as the 'recipient') establishes a guaranty or
undertaking that--
''(i) is signed by, and contains the name and
address of, a person residing in the United States from
whom the recipient received in good faith the food
(including the receipt of seeds to grow raw
agricultural commodities); and
''(ii) contains a statement to the effect that the
food is not genetically engineered or does not contain
a genetically engineered ingredient.
''(B) In the case of a recipient who, with respect to a
food, establishes a guaranty or undertaking in accordance with
subparagraph (A), the exclusion under such subparagraph from
being subject to penalties applies to the recipient without
regard to the manner in which the recipient uses the food,
including whether the recipient is--
''(i) processing the food;
''(ii) using the food as an ingredient in a food
product;
''(iii) repacking the food; or
''(iv) growing, raising, or otherwise producing the
food.
''(C) No person may avoid responsibility or liability for a
violation of subsection (a), (b), or (c) of section 301
involving food that is misbranded within the meaning of section
403(z) by entering into a contract or other agreement that
specifies that another person shall bear such responsibility or
liability, except that a recipient may require a guaranty or
undertaking as described in this subsection.
''(D) In this subsection, the terms 'genetically
engineered' and 'genetically engineered ingredient' have the
meanings given the terms in section 403(z).''.
(2) False guaranty.--Section 301(h) of the Federal Food,
Drug, and Cosmetic Act (21 U.S.C. 331(h)) is amended by
inserting ''or 303(d)(2)'' after ''section 303(c)(2)''.
(c) Unintended Contamination.--Section 303(d) of the Federal Food,
Drug, and Cosmetic Act (21 U.S.C. 333(d)), as amended by subsection
(b), is further amended by adding at the end the following:
''(3)(A) No person shall be subject to the penalties of
subsection (a)(1) for a violation of subsection (a), (b), or
(c) of section 301 involving food that is misbranded within the
meaning of section 403(z) if--
''(i) such person is an agricultural producer and
the violation occurs because food that is grown,
raised, or otherwise produced by such producer, which
food does not contain a genetically engineered material
and was not produced with a genetically engineered
material, is contaminated with a food that contains a
genetically engineered material or was produced with a
genetically engineered material; and
''(ii) such contamination is not intended by the
agricultural producer.
''(B) Subparagraph (A) does not apply to an agricultural
producer to the extent that the contamination occurs as a
result of the negligence of the producer.''.
(d) Promulgation of Regulations.--Not later than 1 year after the
date of enactment of this Act, the Secretary shall promulgate proposed
regulations establishing labeling requirements for compliance in
accordance with section 403(z) of the Federal Food, Drug, and Cosmetic
Act, as added by subsection (a).

A: Genetically Engineered Food Right-to-Know Act - Amends the Federal Food, Drug, and Cosmetic Act to deem misbranded any food that has been genetically engineered or contains one or more genetically engineered ingredients, unless such information is clearly disclosed. Exempts from this requirement any food that: (1) is served in restaurants or other similar eating establishments, (2) is a medical food, (3) would be subject to such requirement solely because it was produced using a genetically engineered vaccine, or (4) would be subject to such requirement solely because it includes the use of a genetically engineered processing aid (including yeast) or enzyme. Defines "genetically engineered" as a material intended for human consumption that is: (1) an organism produced through the intentional use of genetic engineering, or (2) the progeny of intended sexual or asexual reproduction (or both) of one or more organisms that is the product of genetic engineering. Defines "genetically engineered ingredient" as an ingredient in a food that is derived from any part of an organism that has been genetically engineered, without regard to whether: (1) the altered molecular or cellular characteristics of the organism are detectable in the material, and (2) the organism is capable for use as human food. Excludes from penalties for misbranding of genetically engineered food or ingredients any recipient that establishes a guaranty or undertaking that: (1) is signed by, and contains the name and address of, a person residing in the United States from whom the recipient received the food in good faith (including the receipt of seeds to grow raw agricultural commodities); and (2) contains a statement to the effect that the food is not genetically engineered or does not contain a genetically engineered ingredient. Applies this exclusion from penalties without regard to the manner in which the recipient uses the food. Excludes an agricultural producer also from such penalties when a violation occurs because food the producer has grown, raised, or otherwise produced, which neither contains nor was produced with a genetically engineered material, is subsequently contaminated with a food that does contain or was produced with a genetically engineered material, and the agricultural producer has not intended any such contamination nor was negligent in the matter.
****
Q: SECTION 1. SHORT TITLE.

This Act may be cited as the ''Freedom and Mobility in Consumer
Banking Act''.

SEC. 2. FEDERAL DEPOSIT INSURANCE ACT AMENDMENTS.

The Federal Deposit Insurance Act (12 U.S.C. 1811 et seq.) is
amended by adding at the end the following new section:

''SEC. 51. RIGHT TO CLOSE PERSONAL CHECKING AND SAVINGS ACCOUNTS.

''(a) In General.--An insured depository institution may not--
''(1) prohibit any person from closing a checking or
savings account, regardless of whether the balance in the
account is positive, zero, or negative; or
''(2) charge any fee to close any such account.
''(b) Time Limit.--An account at any insured depository institution
shall be closed by the institution not later than 48 hours after
receiving a request from the customer to close the account.
''(c) Methods of Requesting Closure of an Account.--
''(1) In general.--Any accountholder of an account at an
insured depository institution may request that the account be
closed in person, over the phone, or by other electronic or
remote means, as may be prescribed by regulation.
''(2) Exception for large accounts.--Notwithstanding
paragraph (1), any insured depository institution may require
an accountholder of an account which has an outstanding balance
of $25,000 or more on deposit at the depository institution to
close the account in person, to the extent the depository
institution has provided written notice of such requirement to
the account holder at any time prior to receiving a request
from the accountholder to close the account.
''(d) Repayment of Balances.--
''(1) In general.--Any balance in an account at an insured
depository institution that is closed by the institution
pursuant to a request by the accountholder shall repaid to the
accountholder in accordance with the following requirements:
''(A) In person.--If the request is made in person,
the total amount of funds on deposit in the account
shall be paid to the accountholder at the time the
request is made at the consumer's option and without a
fee, by certified check provided to the consumer at the
time of the request, by electronic fund transfer
executed on that business day to an account designated
by the consumer, or by any other means offered by the
financial institution if requested by the consumer.
''(B) Request made by other means.--If the request
is made over the phone, or by other electronic or
remote means, the total amount of funds on deposit in
the account shall promptly be remitted by the
institution to the accountholder at the consumer's
option and without a fee, by certified check issued on
the business day on which the request is received, by
electronic fund transfer executed on that business day
to an account designated by the consumer, or by any
other means offered by the financial institution if
requested by the consumer.
''(2) Time limit.--In any case, the payment by an insured
depository institution of the total amount of funds on deposit
in an account at the institution which the accountholder has
requested be closed shall be remitted to the accountholder
before the end of the 3 business day period beginning when the
accountholder submits such request.
''(e) Prohibition on Any Fees or Charges After Request To Close.--
No insured depository institution may impose any fees or charges on any
deposit account at such institution after receiving a request in
accordance with subsection (c) to close the account.
''(f) Prohibition on Reopening Account To Make Subsequent
Payment.--No insured depository institution may reopen an account that
the consumer has requested be closed in accordance with subsection (c)
to apply subsequent debits, whether preauthorized or otherwise, or for
any other reason, unless the consumer expressly requests that such
account be reopened.
''(g) Notice of Subsequent Preauthorized Recurring Debits.--During
the 30-day period beginning on the date an account at an insured
depository institution is closed pursuant to a request by the
accountholder, the insured depository institution shall promptly notify
the customer if a preauthorized recurring debit is directed to the
account.
''(h) Limitation on Reporting.--
''(1) Negative balance resulting from fees.--If, at the
time any account at an insured depository institution is
closed, the account has a negative balance resulting solely
from any fee assessed by the depository institution, the
insured depository institution may not report the fact of the
outstanding balance or any other adverse information with
respect to such account to any consumer reporting agency
described in section 603(f) of the Fair Credit Reporting Act if
such information could be used to adversely affect the
consumer's ability to open a transaction account at another
depository institution.
''(2) Treatment of negative balance resulting from
overdrafts.--If such information could be used to adversely
affect the consumer's ability to open a transaction account at
another depository institution, an insured depository
institution shall not report to any consumer reporting agency
(as defined in section 603 of the Fair Credit Reporting Act)
that an account had a negative balance at the time of the
closure of the account unless all of the following conditions
are met:
''(A) Only if the negative balance is the result of
funds actually paid by the depository institution to a
third party.
''(B) Only for the amount it actually paid to the
third party and not for any fees associated with the
transaction.
''(C) Only to the extent the negative balance is
the result of credit extended through an overdraft line
of credit program where the fee or charge incurred in
connection with the overdraft is considered a finance
charge under the Truth In Lending Act.
''(3) Notice and opportunity for repayment of overdraft.--
If an account of an accountholder at an insured depository
institution has a negative balance at the time the account is
closed, the insured depository institution--
''(A) shall promptly notify the accountholder of
the fact of the negative balance and the amount due;
and
''(B) may, after the end of the 30-day period
beginning on the date notice is provided to an
accountholder under subparagraph (A)--
''(i) report the fact of the outstanding
balance or any other adverse information with
respect to such account to any consumer
reporting agency, subject to the limitations in
paragraph (2); and
''(ii) take any other collection activity
with respect to such outstanding balance.
''(i) Transfer of Direct Deposit Received After Notice of Closure
and Payment.--If--
''(1) during the 30-day period beginning after any balance
in an account at an insured depository institution that is
closed by the institution pursuant to a request by the
accountholder has been repaid to the accountholder, a
previously scheduled amount intended for direct deposit into
such account is received by such institution, and
''(2) before the time such amount is received, the consumer
provides the insured depository institution with an account
number and insured depository institution routing number for a
successor transaction or savings account at another insured
depository institution,
the insured depository institution which receives such amount shall
transfer such amount, without a fee and by electronic fund transfer, to
the insured depository institution identified by the former
accountholder for deposit in the transaction or savings account
identified by such former accountholder.
''(j) Regulations.--The Federal banking agencies shall jointly
prescribe regulations to carry out the purposes of this section.''.

A: Freedom and Mobility in Consumer Banking Act - Amends the Federal Deposit Insurance Act (FDIA) to prohibit an insured depository institution from: (1) prohibiting any person from closing a checking or savings account, regardless of its balance; or (2) charging a fee to close such an account.

Requires a depository institution to close an account within 48 hours after receiving a request from the customer to do so.

Permits an account holder to request that the account be closed in person, over the phone, or by other electronic or remote means, as may be prescribed by regulation.

Sets forth financial institution procedures for closing large accounts and repaying balances, as well as notice and opportunity for accountholder repayment of overdrafts.

Prohibits a depository institution from: (1) imposing fees or charges after receiving a request to close an account, or (2) reopening an account without express account holder request.
****
Q: SECTION 1. SHORT TITLE.

This Act may be cited as the ''Treat and Reduce Obesity Act of
2013''.

SEC. 2. FINDINGS.

Congress makes the following findings:
(1) According to the Centers for Disease Control and
Prevention, about 35 percent of adults aged 65 and over were
obese in the period of 2007 through 2010, representing over 8
million adults aged 65 through 74.
(2) Obesity increases the risk for chronic diseases and
conditions, including high blood pressure, heart disease, and
type 2 diabetes.
(3) More than half of Medicare beneficiaries are treated
for 5 or more chronic conditions per year. The rate of obesity
among Medicare patients doubled from 1987 to 2002, and spending
on those individuals more than doubled.
(4) Obese men and women at age 65 have decreased life
expectancy of 1.6 years for men and 1.4 years for women.
(5) The direct and indirect cost of obesity is more than
$450 billion annually.
(6) On average, an obese Medicare beneficiary costs $1,964
more than a normal-weight beneficiary.
(7) The prevalence of obesity among older Americans is
growing at a linear rate and, left unchanged, nearly half of
the elderly population will be obese in 2030 according to a
Congressional Research Report on obesity.

SEC. 3. INCLUSION OF INFORMATION ON COVERAGE OF INTENSIVE BEHAVIORAL
THERAPY FOR OBESITY IN THE MEDICARE AND YOU HANDBOOK.

(a) In General.--Section 1804(a) of the Social Security Act (42
U.S.C. 1395b-2(a)) is amended--
(1) in paragraph (2), by striking ''and'' at the end;
(2) in paragraph (3), by striking the period at the end and
inserting '', and''; and
(3) by inserting after paragraph (3) the following new
paragraph:
''(4) information on the coverage of intensive behavioral
therapy for obesity under this title, including information
regarding primary care physicians and other providers of
services and suppliers who are eligible to furnish such
therapy.''.
(b) Effective Date.--The amendments made by this section shall
apply to notices distributed on or after the date of enactment of this
Act.

SEC. 4. PLAN FOR COORDINATION OF HHS EFFORTS; PROVIDING THE SECRETARY
OF HEALTH AND HUMAN SERVICES WITH AUTHORITY TO COORDINATE
PROGRAMS TO PREVENT AND TREAT OBESITY AND EXPAND COVERAGE
OPTIONS FOR OBESITY UNDER MEDICARE.

Section 1861(ddd) of the Social Security Act (42 U.S.C.
1395x(ddd)), as amended by section 3, is amended by adding at the end
the following new paragraph:
''(5)(A) Not later than 1 year after the date of enactment of the
Treat and Reduce Obesity Act of 2013, the Secretary shall develop and
implement a plan to coordinate the efforts of all offices and agencies
of the Department of Health and Human Services (such as the Centers for
Medicare & Medicaid Services, the Centers for Disease Control and
Prevention, the National Institutes of Health, the Health Resources and
Services Administration, and other offices and agencies) to treat,
reduce, and prevent obesity and overweight in the adult population.
Beginning 2 years after such date of enactment, the Secretary shall
annually update such plan.
''(B) In developing and implementing the plan under subparagraph
(A), the Secretary shall work with at least 5 representatives, selected
by the Secretary, of expert organizations (such as public health
associations, physician associations, key healthcare provider groups,
planning and development organizations, education associations,
advocacy groups, patient groups, relevant industries, State and local
leadership, and other entities as determined appropriate by the
Secretary).
''(C) The Secretary shall ensure that the plan under subparagraph
(A) is coordinated with the National Prevention Strategy and does not
duplicate the efforts of the National Prevention Council and the
National Prevention Strategy.
''(D) The plan under subparagraph (A) shall include the following:
''(i) Strategies to comprehensively treat and reduce
overweight and obesity.
''(ii) A description of--
''(I) the coordination of interagency cooperation
under the plan; and
''(II) actions under the plan related to the
treatment and reduction of overweight and obesity in
the United States.
''(iii) Identification of best practices in States,
communities, organizations, businesses, and other entities as
appropriate, regarding treatment of overweight and obesity.
''(iv) A description of collaboration with States,
communities, organizations, businesses, and other appropriate
entities to evaluate the effectiveness of obesity and
overweight interventions under the plan.
''(v) Research initiatives, including ongoing surveillance
and monitoring using tools such as the National Health and
Nutrition Examination Survey and the Behavioral Risk Factor
Surveillance System and assurances for adequate and consistent
funding to support data collection and analysis to inform
policy under the plan.
''(vi) Recommendations for the coordination of budgets,
grant and pilot programs, policies, and programs across Federal
agencies to cohesively treat overweight and obesity.
''(E) Not later than 24 months after the date of enactment of the
Treat and Reduce Obesity Act of 2013, and on an annual basis
thereafter, the Secretary shall submit to the President and to the
relevant committees of Congress, a report that--
''(i) summarizes the plan under subparagraph (A) to
coordinate interagency efforts surrounding the treatment,
reduction, and prevention of obesity and overweight, including
a detailed strategic plan with recommendations for each office
and agency involved;
''(ii) in the case of the second report submitted under
this subparagraph (and each subsequent report), evaluates the
effectiveness of those coordinated interventions and conducts
interim assessments and reporting of health outcomes,
achievement of milestones, and implementation of strategic plan
goals; and
''(iii) makes recommendations for updating the plan for the
following year based on data and findings from the previous
year.''.

SEC. 5. AUTHORITY TO EXPAND HEALTH CARE PROVIDERS QUALIFIED TO FURNISH
INTENSIVE BEHAVIORAL THERAPY.

Section 1861(ddd) of the Social Security Act (42 U.S.C.
1395x(ddd)), as amended by sections 3 and 4, is amended by adding at
the end the following new paragraph:
''(6)(A) The Secretary may, in addition to qualified primary care
physicians and other primary care practitioners, cover intensive
behavioral therapy for obesity--
''(i) furnished by a physician (as defined in subsection
(r)(1)) who is not a qualified primary care physician;
''(ii) furnished--
''(I) by any other appropriate health care provider
(including a physician assistant, nurse practitioner,
or clinical nurse specialist (as those terms are
defined in subsection (aa)(5)), a clinical
psychologist, and a registered dietitian or nutrition
professional (as defined in subsection (vv));
''(II) upon referral from, and in coordination
with, a physician or primary care practitioner
operating in a primary care setting or any other
setting specified by the Secretary; and
''(III) in an office setting, a hospital outpatient
department, or another setting specified by the
Secretary; or
''(iii) furnished by an evidence-based, community-based
lifestyle counseling program certified by the Secretary.
''(B) In order to ensure a collaborative effort, the coordination
described in subparagraph (A)(ii)(II) may include the health care
provider communicating to the physician or primary care practitioner
making the referral any recommendations or treatment plans made
regarding the therapy.''.

SEC. 6. MEDICARE PART D COVERAGE OF OBESITY MEDICATION.

(a) In General.--Section 1860D-2(e)(2)(A) of the Social Security
Act (42 U.S.C. 1395w-102(e)(2)(A)) is amended by inserting after
''restricted under section 1927(d)(2),'' the following, ''other than
subparagraph (A) of such section if the drug is used for the treatment
of obesity (as defined for purposes of section 1861(yy)(2)(C)) or for
being overweight (as defined for purposes of section 1861(yy)(2)(F)(i))
and if the individual has one or more comorbidities,''.
(b) Effective Date.--The amendment made by subsection (a) shall
apply to plan years beginning on or after the date that is 2 years
after the date of enactment of this Act.

A:
Treat and Reduce Obesity Act of 2013 - Amends title XVIII (Medicare) of the Social Security Act to include information on the coverage of intensive behavioral therapy for obesity in the "Medicare and You Handbook." Directs the Secretary of Health and Human Services (HHS) to develop and implement a plan to coordinate the efforts of all HHS officers and agencies to treat, reduce, and prevent obesity and overweight in the adult population. Authorizes the Secretary, in addition to qualified primary care physicians and other primary care practitioners, to cover intensive behavioral therapy for obesity furnished by: (1) a physician who is not a qualified primary care physician; (2) an evidence-based, community-based HHS-certified lifestyle counseling program; or (3) any other appropriate health care provider (including a physician assistant, nurse practitioner, clinical nurse specialist, a clinical psychologist, and a registered dietitian or nutrition professional) upon referral from, and in coordination with, a physician or primary care practitioner in an office setting, a hospital outpatient department, or another HHS-specified setting. Authorizes the Secretary to cover under Medicare part D (Voluntary Prescription Drug Benefit Program) medication for treatment of obesity or for being overweight for individuals with one or more comorbidities.
****